The trade group for the pharmaceutical industry on Friday sued to block a new process, outlined by the Trump administration, that aimed to help drug makers and health care providers resolve disputes over a federal drug discount program.
The trade group for the pharmaceutical industry on Friday sued to block a new process, outlined by the Trump administration, that aimed to help drug makers and health care providers resolve disputes over a federal drug discount program.